Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC)
European journal of heart failure, 2022-03, Vol.24 (3), p.406 [Peer Reviewed Journal]2021 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. ;ISSN: 1879-0844 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.2414 ;PMID: 34969177
Digital Resources/Online E-Resources